#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

DNA Methylation Dynamics in Human Induced Pluripotent Stem Cells over Time


Epigenetic reprogramming is a critical event in the generation of induced pluripotent stem cells (iPSCs). Here, we determined the DNA methylation profiles of 22 human iPSC lines derived from five different cell types (human endometrium, placental artery endothelium, amnion, fetal lung fibroblast, and menstrual blood cell) and five human embryonic stem cell (ESC) lines, and we followed the aberrant methylation sites in iPSCs for up to 42 weeks. The iPSCs exhibited distinct epigenetic differences from ESCs, which were caused by aberrant methylation at early passages. Multiple appearances and then disappearances of random aberrant methylation were detected throughout iPSC reprogramming. Continuous passaging of the iPSCs diminished the differences between iPSCs and ESCs, implying that iPSCs lose the characteristics inherited from the parent cells and adapt to very closely resemble ESCs over time. Human iPSCs were gradually reprogrammed through the “convergence” of aberrant hyper-methylation events that continuously appeared in a de novo manner. This iPS reprogramming consisted of stochastic de novo methylation and selection/fixation of methylation in an environment suitable for ESCs. Taken together, random methylation and convergence are driving forces for long-term reprogramming of iPSCs to ESCs.


Vyšlo v časopise: DNA Methylation Dynamics in Human Induced Pluripotent Stem Cells over Time. PLoS Genet 7(5): e32767. doi:10.1371/journal.pgen.1002085
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1002085

Souhrn

Epigenetic reprogramming is a critical event in the generation of induced pluripotent stem cells (iPSCs). Here, we determined the DNA methylation profiles of 22 human iPSC lines derived from five different cell types (human endometrium, placental artery endothelium, amnion, fetal lung fibroblast, and menstrual blood cell) and five human embryonic stem cell (ESC) lines, and we followed the aberrant methylation sites in iPSCs for up to 42 weeks. The iPSCs exhibited distinct epigenetic differences from ESCs, which were caused by aberrant methylation at early passages. Multiple appearances and then disappearances of random aberrant methylation were detected throughout iPSC reprogramming. Continuous passaging of the iPSCs diminished the differences between iPSCs and ESCs, implying that iPSCs lose the characteristics inherited from the parent cells and adapt to very closely resemble ESCs over time. Human iPSCs were gradually reprogrammed through the “convergence” of aberrant hyper-methylation events that continuously appeared in a de novo manner. This iPS reprogramming consisted of stochastic de novo methylation and selection/fixation of methylation in an environment suitable for ESCs. Taken together, random methylation and convergence are driving forces for long-term reprogramming of iPSCs to ESCs.


Zdroje

1. LiE 2002 Chromatin modification and epigenetic reprogramming in mammalian development. Nat Rev Genet 3 662 673

2. ReikW 2007 Stability and flexibility of epigenetic gene regulation in mammalian development. Nature 447 425 432

3. FengSJacobsenSEReikW 2010 Epigenetic reprogramming in plant and animal development. Science 330 622 627

4. HattoriNNishinoKKoYGOhganeJTanakaS 2004 Epigenetic control of mouse Oct-4 gene expression in embryonic stem cells and trophoblast stem cells. J Biol Chem 279 17063 17069

5. HattoriNImaoYNishinoKOhganeJYagiS 2007 Epigenetic regulation of Nanog gene in embryonic stem and trophoblast stem cells. Genes Cells 12 387 396

6. NishinoKHattoriNTanakaSShiotaK 2004 DNA methylation-mediated control of Sry gene expression in mouse gonadal development. J Biol Chem 279 22306 22313

7. ZinggJMPedraza-AlvaGJostJP 1994 MyoD1 promoter autoregulation is mediated by two proximal E-boxes. Nucleic Acids Res 22 2234 2241

8. TakahashiKTanabeKOhnukiMNaritaMIchisakaT 2007 Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131 861 872

9. YuJVodyanikMASmuga-OttoKAntosiewicz-BourgetJFraneJL 2007 Induced pluripotent stem cell lines derived from human somatic cells. Science 318 1917 1920

10. ParkIHZhaoRWestJAYabuuchiAHuoH 2008 Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451 141 146

11. WoltjenKMichaelIPMohseniPDesaiRMileikovskyM 2009 piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 458 766 770

12. ParkIHAroraNHuoHMaheraliNAhfeldtT 2008 Disease-specific induced pluripotent stem cells. Cell 134 877 886

13. MiuraKOkadaYAoiTOkadaATakahashiK 2009 Variation in the safety of induced pluripotent stem cell lines. Nat Biotechnol 27 743 745

14. GhoshZWilsonKDWuYHuSQuertermousT 2010 Persistent donor cell gene expression among human induced pluripotent stem cells contributes to differences with human embryonic stem cells. PLoS ONE 5 e8975 doi:10.1371/journal.pone.0008975

15. PoloJMLiuSFigueroaMEKulalertWEminliS 2010 Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nat Biotechnol 28 848 855

16. KimKDoiAWenBNgKZhaoR 2010 Epigenetic memory in induced pluripotent stem cells. Nature

17. NishinoKToyodaMYamazaki-InoueMMakinoHFukawataseY 2010 Defining Hypo-Methylated Regions of Stem Cell-Specific Promoters in Human iPS Cells Derived from Extra-Embryonic Amnions and Lung Fibroblasts. PLoS ONE 5 e13017 doi:10.1371/journal.pone.0013017

18. FazzariMJGreallyJM 2004 Epigenomics: beyond CpG islands. Nat Rev Genet 5 446 455

19. FazzariMJGreallyJM 2010 Introduction to epigenomics and epigenome-wide analysis. Methods Mol Biol 620 243 265

20. DoiAParkIHWenBMurakamiPAryeeMJ 2009 Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nat Genet 41 1350 1353

21. ListerRPelizzolaMKidaYSHawkinsRDNeryJR 2011 Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature 471 68 73

22. BockCKiskinisEVerstappenGGuHBoultingG 2011 Reference Maps of Human ES and iPS Cell Variation Enable High-Throughput Characterization of Pluripotent Cell Lines. Cell 144 439 452

23. CowanCAKlimanskayaIMcMahonJAtienzaJWitmyerJ 2004 Derivation of embryonic stem-cell lines from human blastocysts. N Engl J Med 350 1353 1356

24. OsafuneKCaronLBorowiakMMartinezRJFitz-GeraldCS 2008 Marked differences in differentiation propensity among human embryonic stem cell lines. Nat Biotechnol 26 313 315

25. BrenaRMAuerHKornackerKPlassC 2006 Quantification of DNA methylation in electrofluidics chips (Bio-COBRA). Nat Protoc 1 52 58

26. TakahashiKYamanakaS 2006 Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126 663 676

27. HuangfuDOsafuneKMaehrRGuoWEijkelenboomA 2008 Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat Biotechnol 26 1269 1275

28. FouseSDShenYPellegriniMColeSMeissnerA 2008 Promoter CpG methylation contributes to ES cell gene regulation in parallel with Oct4/Nanog, PcG complex, and histone H3 K4/K27 trimethylation. Cell Stem Cell 2 160 169

29. MeissnerAMikkelsenTSGuHWernigMHannaJ 2008 Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature 454 766 770

30. SatoSYagiSAraiYHirabayashiKHattoriN 2010 Genome-wide DNA methylation profile of tissue-dependent and differentially methylated regions (T-DMRs) residing in mouse pluripotent stem cells. Genes Cells 15 607 618

31. ChinMHPellegriniMPlathKLowryWE 2010 Molecular analyses of human induced pluripotent stem cells and embryonic stem cells. Cell Stem Cell 7 263 269

32. MaheraliNSridharanRXieWUtikalJEminliS 2007 Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 1 55 70

33. HallLLByronMButlerJBeckerKANelsonA 2008 X-inactivation reveals epigenetic anomalies in most hESC but identifies sublines that initiate as expected. J Cell Physiol 216 445 452

34. ShenYMatsunoYFouseSDRaoNRootS 2008 X-inactivation in female human embryonic stem cells is in a nonrandom pattern and prone to epigenetic alterations. Proc Natl Acad Sci U S A 105 4709 4714

35. LengnerCJGimelbrantAAErwinJAChengAWGuentherMG 2010 Derivation of pre-X inactivation human embryonic stem cells under physiological oxygen concentrations. Cell 141 872 883

36. TchieuJKuoyEChinMHTrinhHPattersonM 2010 Female human iPSCs retain an inactive X chromosome. Cell Stem Cell 7 329 342

37. Rugg-GunnPJFerguson-SmithACPedersenRA 2005 Epigenetic status of human embryonic stem cells. Nat Genet 37 585 587

38. Rugg-GunnPJFerguson-SmithACPedersenRA 2007 Status of genomic imprinting in human embryonic stem cells as revealed by a large cohort of independently derived and maintained lines. Hum Mol Genet 16 Spec No. 2 R243 251

39. StadtfeldMApostolouEAkutsuHFukudaAFollettP 2010 Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells. Nature 465 175 181

40. KagamiMSekitaYNishimuraGIrieMKatoF 2008 Deletions and epimutations affecting the human 14q32.2 imprinted region in individuals with paternal and maternal upd(14)-like phenotypes. Nat Genet 40 237 242

41. NagataSToyodaMYamaguchiSHiranoKMakinoH 2009 Efficient reprogramming of human and mouse primary extra-embryonic cells to pluripotent stem cells. Genes Cells 14 1395 1404

42. CuiCHUyamaTMiyadoKTeraiMKyoS 2007 Menstrual blood-derived cells confer human dystrophin expression in the murine model of Duchenne muscular dystrophy via cell fusion and myogenic transdifferentiation. Mol Biol Cell 18 1586 1594

43. JacobsJPJonesCMBailleJP 1970 Characteristics of a human diploid cell designated MRC-5. Nature 227 168 170

44. MakinoHToyodaMMatsumotoKSaitoHNishinoK 2009 Mesenchymal to embryonic incomplete transition of human cells by chimeric OCT4/3 (POU5F1) with physiological co-activator EWS. Exp Cell Res 315 2727 2740

45. SaitoSOnumaYItoYTatenoHToyodaM 2010 Potential linkages between the inner and outer cellular states of human induced pluripotent stem cells. BMC Bioinformatics in press

46. ToyodaMYamazaki-InoueMItakuraYKunoAOgawaT 2010 Lectin microarray analysis of pluripotent and multipotent stem cells. Genes Cells in press

47. KumakiYOdaMOkanoM 2008 QUMA: quantification tool for methylation analysis. Nucleic Acids Res 36 W170 175

48. SharovAADudekulaDBKoMS 2005 A web-based tool for principal component and significance analysis of microarray data. Bioinformatics 21 2548 2549

49. Huang daWShermanBTLempickiRA 2009 Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4 44 57

50. MiHLazareva-UlitskyBLooRKejariwalAVandergriffJ 2005 The PANTHER database of protein families, subfamilies, functions and pathways. Nucleic Acids Res 33 D284 288

Štítky
Genetika Reprodukčná medicína

Článok vyšiel v časopise

PLOS Genetics


2011 Číslo 5
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Aktuální možnosti diagnostiky a léčby litiáz
nový kurz
Autori: MUDr. Tomáš Ürge, PhD.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#